Wordt geladen...
NF‐κB/NKILA signaling modulates the anti‐cancerous effects of EZH2 inhibition
A wealth of evidence supports the broad therapeutic potential of NF‐κB and EZH2 inhibitors as adjuvants for breast cancer treatment. We contribute to this knowledge by elucidating, for the first time, unique regulatory crosstalk between EZH2, NF‐κB and the NF‐κB interacting long non‐coding RNA (NKIL...
Bewaard in:
| Gepubliceerd in: | J Cell Mol Med |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6714229/ https://ncbi.nlm.nih.gov/pubmed/31282094 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14500 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|